7. Discussion
The PARAGEN collection's contribution to the biotechnological arsenal against antibiotic resistance is undeniable. The large number of bacteriocins it offers, and the speed with which their activities can be screened thanks to in vitro production, open up promising prospects for therapeutic and industrial innovation. The potential of bacteriocins makes them a family of molecules aligned with the "One Health" concept, and promises to be used in the fields of animal, human and environmental health
The Ultimate Scientific and Technical Reference
This article is included in
Bioprocesses and bioproductions
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Discussion
Conclusion
Bibliography
Patents
Controlled growth of microorganisms. US Patent 9,333,227 / 10,188,114 + CN Patent ZL 201480057387.2 + EP3035802B1 + BR1120160035330 + IN389267
Engineering bacteriocins. US Patent Application 62681529 (filed June 6, 2018)
Bacteriocin for new application. Patent Application 2022/253743 A1 (filed 30 May 2022)
Cerein 7B bacteriocin for new application. Patent...
The Ultimate Scientific and Technical Reference
